Pharmacy
The agreement settles allegations that Walmart failed to confirm and document the necessary diagnoses for Code 1 drugs.
One of the main culprits is the "buy-and-bill" reimbursement model for infused therapies.
Expert Julie Hurley will address pitfalls in "Securing and Illuminating the Pharmaceutical Supply Chain" webinar Wednesday.
Documents reveal behind-the-scenes discussions influenced by pharmaceutical industry, led by former Gilead lobbyist Joe Grogan.
Some high-priced drugs like Sovaldi, a hepatitis C drug which initially cost $84,000, involved no rebates until other competitors came to market.
Costs for prescription drugs have been rising faster than those for any other health segment, marked by high-profile cases like EpiPen and Daraprim.
Many of the 1.25 million Americans who live with Type 1 diabetes cheered the effort as an important first step in their fight against soaring costs.
The findings suggest that the move by CMS to remove pain management from consideration will have little effect on hospital payments.
Best way to address these problems is to create greater transparency, and simplify the pricing structure, PRI says.
Scott Gottlieb and Gopal Khanna round out the most recent government hires to head the agencies most important to health IT.